MIRA Pharmaceuticals
MIRA
29 hedge funds and large institutions have $1.89M invested in MIRA Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 1 closing their positions.
900% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 1
800% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 1
56% more capital invested
Capital invested by funds: $1.21M → $1.89M (+$682K)
45% more funds holding
Funds holding: 20 → 29 (+9)
1.41% more ownership
Funds ownership: 5.91% → 7.32% (+1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$159K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$125K |
| 3 |
Renaissance Technologies
New York
|
+$67.8K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$43.7K |
| 5 |
FAB
First American Bank
Dundee,
Illinois
|
+$43.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFO
Fortitude Family Office
Scottsdale,
Arizona
|
-$935 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$412 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
UBS Group
Zurich,
Switzerland
| $294 | -$412 | -284 | -57% |
|
27
Bank of America
Charlotte,
North Carolina
| $190 | +$30 | +21 | +18% |
|
28
Fidelity Investments
Boston,
Massachusetts
| $156 | +$167 | +115 | New |
|
29
Wells Fargo
San Francisco,
California
| $31 | +$33 | +23 | New |
|
|
FFO
30
Fortitude Family Office
Scottsdale,
Arizona
| – | -$935 | -773 | Closed |
|
MIRA Hedge Fund Activity: Q3 2025 in Review
29 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in MIRA Pharmaceuticals (MIRA) for Q3 2025, worth a combined $1.89M — up 56% from $1.21M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new MIRA positions and 1 closed out — a net gain of 9 holders — while 9 added to existing stakes and 1 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $159K. The largest seller was Fortitude Family Office, exiting entirely with an estimated $935 sold.
- 29 institutional investors held MIRA Pharmaceuticals (MIRA) as of Q3 2025, up from 20 in Q2 2025.
- Funds reported $1.89M of MIRA Pharmaceuticals stock for Q3 2025, up 56% quarter-over-quarter.
- 10 funds opened new MIRA Pharmaceuticals positions in Q3 2025 and 1 closed out, a net change of +9 holders.
- The largest MIRA Pharmaceuticals buyer in Q3 2025 was BlackRock, an estimated $159K added.
- The largest MIRA Pharmaceuticals seller in Q3 2025 was Fortitude Family Office, an estimated $935 sold.
Based on aggregated 13F filings for Q3 2025.